CEBPA and fatty liver disease: Our study firstly revealed that G. cambogia and HCA inhibited HFD- and FFA-induced C/EBPα and PPARγ activation by reducing intracellular ROS levels and leading to suppression of lipogenic gene transcription and hepatic steatosis (Figure 1, Figure 3A,B and Figure 5).